Theravance Biopharma presents at Needham Healthcare Conference; no material news disclosed

Theravance Biopharma, Inc.

Management team presented at 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023.
Slide deck furnished as Exhibit 99.1 contains only a title slide; no financial or pipeline updates provided.
Filing under Item 7.01 is for Regulation FD purposes and is not deemed filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.